BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10793080)

  • 1. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.
    Gimm O; Perren A; Weng LP; Marsh DJ; Yeh JJ; Ziebold U; Gil E; Hinze R; Delbridge L; Lees JA; Mutter GL; Robinson BG; Komminoth P; Dralle H; Eng C
    Am J Pathol; 2000 May; 156(5):1693-700. PubMed ID: 10793080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.
    Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D
    Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.
    Eng C
    Recent Prog Horm Res; 1999; 54():441-52; discussion 453. PubMed ID: 10548886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
    Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
    Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN promoter methylation in sporadic thyroid carcinomas.
    Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
    Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
    Yeh JJ; Marsh DJ; Zedenius J; Dwight T; Delbridge L; Robinson BG; Eng C
    Genes Chromosomes Cancer; 1999 Dec; 26(4):322-8. PubMed ID: 10534767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells.
    Perren A; Komminoth P; Saremaslani P; Matter C; Feurer S; Lees JA; Heitz PU; Eng C
    Am J Pathol; 2000 Oct; 157(4):1097-103. PubMed ID: 11021813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
    Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
    Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.
    Perren A; Weng LP; Boag AH; Ziebold U; Thakore K; Dahia PL; Komminoth P; Lees JA; Mulligan LM; Mutter GL; Eng C
    Am J Pathol; 1999 Oct; 155(4):1253-60. PubMed ID: 10514407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
    Marsh DJ; Dahia PL; Coulon V; Zheng Z; Dorion-Bonnet F; Call KM; Little R; Lin AY; Eeles RA; Goldstein AM; Hodgson SV; Richardson AL; Robinson BG; Weber HC; Longy M; Eng C
    Genes Chromosomes Cancer; 1998 Jan; 21(1):61-9. PubMed ID: 9443042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis.
    Eng C
    Ann N Y Acad Sci; 2002 Jun; 968():213-21. PubMed ID: 12119278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens.
    Puxeddu E; Zhao G; Stringer JR; Medvedovic M; Moretti S; Fagin JA
    Mutat Res; 2005 Feb; 570(1):17-32. PubMed ID: 15680400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN and Egr-1 expression in thyroid proliferative lesions.
    Di Loreto C; Tell G; Pestrin M; Pandolfi M; Damante G; Puglisi F
    Cancer Lett; 2005 Jun; 224(1):105-9. PubMed ID: 15911105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M; Delahunt B; McIver B; Grebe SK
    Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.